NewsRamp provides syndicated and curated news distribution and marketing services for major newswires.
May 10, 2025 — Dr. Ira L Shapira introduces innovative treatment methods for TMJ Disorders, including Sphenopalatine Ganglion Blocks. Learn how these techniques can offer fast relief for severe headaches and migraines. Discover the impact of this groundbreaking approach to pain management.
May 9, 2025 — Calidi Biotherapeutics announces promising preclinical results for its RTNova platform, showcasing the potential to revolutionize cancer treatment. With the ability to kill tumor cell lines and activate immune responses, this breakthrough could lead to improved efficacy and patient safety, opening doors for partnerships.
May 9, 2025 — Discover how CNS Pharmaceuticals Inc. is leading the way in innovative treatments for pediatric brain cancer, offering new hope and improved care for young patients. Learn more about medulloblastoma and the latest developments in pediatric oncology.
May 9, 2025 — Nutriband's AVERSA(TM) technology is revolutionizing abuse-deterrent drug delivery amid FDA regulatory changes. Learn how the company is addressing the opioid crisis and providing safer alternatives to opioids.
May 9, 2025 — ABVC BioPharma secures new patent protection for ABV-1504, a botanical-based depression treatment, and enters a $667M global licensing agreement with AiBtl BioPharma. This news showcases the company's commitment to innovation and global expansion in the pharmaceutical industry.
May 9, 2025 — Diplomatic Trade Ltd and Diplomatic Trade Capital Group's investment in Farmakim ilaç Kimya Gida Ürünleri Üretim San ve Dis Tie A.S. marks a pivotal moment in MENA healthcare manufacturing. The joint venture's plans for a bio-manufacturing facility in the UAE and an upcoming IPO listing in the UAE demonstrate a commitment to advancing biotech innovation in the region.
May 9, 2025 — Zil Money Corporation receives HIPAA certification, ensuring data privacy and security for businesses. The certification covers online check printing, ACH transfers, and expense management, providing secure payment solutions.
May 9, 2025 — Apply for the Dr. Michael Lebow Scholarship for Future Doctors today! Receive a $1,000 award for your commitment to healthcare. Deadline for applications is December 15, 2025.
May 9, 2025 — Steve Sanchez of Southeast Colorado Hospital receives 'Rural Health Excellence' award from CRHC for outstanding rural health advocacy. The award underscores the significance of supporting healthcare initiatives in rural communities and honoring individuals dedicated to improving healthcare access.
May 8, 2025 — Adageis is changing the game in healthcare payment management with its AI-driven platform, offering real-time insights and empowering clinics to optimize revenue in the shift to value-based care. Learn how Adageis is revolutionizing insurance payment management and why it's a promising investment opportunity in the healthcare technology sector.
May 8, 2025 — CI conducts annual CHLOREP Team Training at Mississippi State Fire Academy to equip hazmat professionals with skills for responding to chlorine emergencies. The program emphasizes proactive safety measures and the critical role of chlorine in various industries.
May 8, 2025 — Hydromer, Inc. announces Q1 2025 financial results with revenue and net income decline. Strategic investments for growth and innovation emphasized. Investors gain insight into company performance and future trajectory.
May 8, 2025 — Clene announces positive results and progress on CNM-Au8 program for ALS and MS, showcasing potential advancements in neurodegenerative disease treatments and offering hope to patients.
May 8, 2025 — TransCode Therapeutics announces progress in Phase 1a trial for RNA-based cancer therapeutic TTX-MC138, with expanded enrollment and positive safety profile. Promising results show target engagement and potential for treating metastatic tumors.
May 8, 2025 — New research suggests a simple eye exam could detect Parkinson's disease early. Learn about the study findings and how companies like Clene Inc. (NASDAQ: CLNN) are contributing to advancements in PD diagnosis.
May 8, 2025 — Clene announces first quarter 2025 financial results and updates on CNM-Au8 program for ALS and MS. Progress towards potential FDA approval and positive clinical trial results signify a significant step forward in neurodegenerative disease research.
May 8, 2025 — NanoViricides, Inc. (NNVC) secures approval for Phase II clinical trial of NV-387 in Democratic Republic of Congo, showcasing potential breakthrough in antiviral therapy development. The company's innovative approach to targeting multiple viruses could lead to more effective treatments for influenza, RSV, coronaviruses, and orthopoxviruses.
May 8, 2025 — American Heart Association CEO Nancy Brown named to TIME100 Health list for impactful work in heart disease and stroke prevention. Learn more about Brown's initiatives and their global impact on health outcomes.
May 8, 2025 — Scinai Immunotherapeutics reports significant financial gains in 2024, demonstrating success in the biopharma sector. Learn more about the company's revenue increase and growth potential.
May 8, 2025 — GeoVax Labs presents clinical data for GEO-CM04S1 COVID-19 vaccine demonstrating robust immune responses and cross-protection against Mpox. This breakthrough study has significant implications for vaccine development and protection against infectious diseases.